History
History
AHN Biotechnologie GmbH is a prominent player in the life science industry, renowned for its innovative products and consistent growth. Established in 1999, the company was acquired by the Danish CAPP ApS in 2016, a company which itself was founded in 1984. CAPP moved its operations to Germany, where AHN is located, and in 2019, AHN Biotechnologie GmbH expanded its product range by acquiring Maxxline, a company with extensive experience in manufacturing plastic consumables for laboratories. AHN’s state-of-the-art production facility meets the rigorous requirements of top life science brands and distribution companies worldwide, while CAPP is a dependable supplier of liquid handling products that are both innovative and user-friendly, with a focus on premium quality. Maxxline’s cryoware products employ innovative production methods and prioritise the highest level of quality to meet the market’s demands for increased productivity and process reliability. With the recent facility extension in 2022, AHN Biotechnologie GmbH is well-positioned to continue its expansion and innovation in the industry.
1999 ahn founded
January 1, 1999
1999 ahn gegründet
January 1, 1999
2012 ahn acquired by Harvard Bioscience
January 1, 2012
Extension of the manufacturing facility
2012 ahn wird von Harvard Bioscience übernommen
January 1, 2012
Erweiterung der Produktionsstätte
2016 wird ahn von CAPP übernommen
January 1, 2016
CAPP Dänemark verlagert seine Produktion nach Deutschland
2016 ahn acquired by CAPP
January 1, 2016
CAPP Denmark moves its production to Germany
2019 Maxxline wird von AHN übernommen
January 1, 2019
2019 Maxxline acquired by AHN
January 1, 2019
2019 Die AHN Biotechnologie GmbH konsolidiert ihre Produktion in Deutschland
June 21, 2019
Verwaltung von 3 verbundenen Marken: CAPP, ahn und Maxxline
2019 AHN Biotechnologie GmbH consolidates its production in Germany
June 21, 2019
managing 3 associated brands: CAPP, ahn and Maxxline